2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening
Ngai‐Yin Chan(Princess Margaret Hospital), Ben Freedman(Johns Hopkins University), Saravanan Krishinan(Hospital Sultanah Bahiyah), Vien Hoang Long(Institute of Mathematics), Dicky Armein Hanafy(Pelita Harapan University), Bernard Yan(The Royal Melbourne Hospital), J. Orchard(Johns Hopkins University), Yasuo Okumura(Nihon University), He Huang(Wuhan University), Sunu Budhi Raharjo(Pelita Harapan University), Bobby John(Townsville Hospital), Boyoung Joung(Yonsei University), Dean Boddington(Tauranga Hospital), Tetsuo Sasano(Tokyo Medical and Dental University), Rungroj Krittayaphong(Siriraj Hospital), Phạm Trần Linh(Institute of Mathematics), Nwe Nwe(East Yangon General Hospital), Yoga Yuniadi(Pelita Harapan University), Toon Wei Lim(National University Heart Centre Singapore), Sofian Johar(Universiti Brunei Darussalam), Ajay Naik(Care Institute of Medical Sciences), Sayaka Kurokawa(Nihon University), Zahid Aslam Awan(Hayatabad Medical Complex), Tze‐Fan Chao(National Yang Ming Chiao Tung University), Michael‐Joseph Agbayani, Chu‐Pak Lau(Goethe University Frankfurt)
Cited by 42
Related Papers
Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events
|Circulation|2014|669
Screening for Atrial Fibrillation
|Circulation|2017|535
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
|Thrombosis and Haemostasis|2021|476
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
|Journal of the American College of Cardiology|2015|258